Puma Biotech’s Delay Increases Headline Risk in 2016
Insights - Puma Biotech (PBYI) on Tuesday evening announced a significant, unexpected delay in its timeline for filing a New Drug Application with the FDA for lead … Continue Reading
Read nowMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Small Drug Companies Get Love on Avanir Buyout
Insights - Japanese drugmaker Otsuka Pharmaceutical Co. is buying US-based Avanir Pharmaceuticals (AVNR) for $3.5 billion, or $17/share, in a deal announced Tuesday morning. Despite a tremendous run … Continue Reading
Read now
Holiday Weeks Always Make for Weird Markets
Recap - A happy (belated) Thanksgiving to you and yours! Last week we wrote briefly about the current state of the markets, from a technical perspective. Conclusion: a short-term pull-back … Continue Reading
Read now
A Short-term Chart Trade and Options Idea for this Upcoming Data Release
Research - This company has a data release coming imminently. We've outlined one equity, and one options strategy for the event.
Premium
Trim this Position for an 18% Gain
Research - This thesis played out beautifully, and it's time to take some profit - 18% in just two weeks.
PremiumOne Simple Chart to Note Before Next Week
Recap - The markets have rebounded precipitously from lows this October, with both the S&P 500 and iShares NASDAQ Biotechnology Index (IBB) making new all-time highs in the … Continue Reading
Read now
In Typical Biotech Fashion, Celldex Rips 40% in a Week’s Time
Insights - Celldex Therapeutics (CLDX) has climbed 100% from all-time lows this summer – 40% in the last week – on encouraging and arguably groundbreaking results from a phase II … Continue Reading
Read now